Taiwan FDA registration ccc07b18de4e9fcf672ef561780b8110
"Bard" Magg preferred to ditch the core tissue sampling needle
TW: “巴德”瑪格寧可拋棄式核心組織取樣針
Taiwan·Risk Class 2·Bard Peripheral Vascular, Inc.;; CareFusion D.R. 203 Ltd.·Registered Mar 02, 2022 – Mar 02, 2027ActiveRegistration details
- Analysis ID
- ccc07b18de4e9fcf672ef561780b8110
- Customs Code
- DHA05603528502
Company information
- Manufacturer Country
- Dominican Republic;;United States
- Authorized Representative
- BARD PACIFIC HEALTH CARE CO., LTD.
Product details
- Intended Use
- Details are as detailed as approved Chinese instructions
- Product Type (Level 1)
- H Gastroenterology and urology
- Product Type (Level 2)
- H.1075 腸胃科-泌尿科生檢器械
- Import Information
- Contract manufacturing;; input
Dates and status
- Registration Date
- Mar 02, 2022
- Expiry Date
- Mar 02, 2027
About this record
Access comprehensive regulatory information for "Bard" Magg preferred to ditch the core tissue sampling needle in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ccc07b18de4e9fcf672ef561780b8110 and manufactured by Bard Peripheral Vascular, Inc.;; CareFusion D.R. 203 Ltd.. The authorized representative in Taiwan is BARD PACIFIC HEALTH CARE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices